Glenmark pharma share price target
About Glenmark :
Glenmark pharmaceuticals Ltd. become incorporated in the yr 1977. Its modern share price is 531.45. Its present day marketplace capitalisation stands at Rs 14995.83 Cr. within the contemporary region, agency has suggested Gross income of Rs. 75679.33 Cr and overall income of Rs.79641.7 Cr. The organization‘s management consists of Harish Kuber, Dipankar Bhattacharjee, DR Mehta, Rajesh V Desai, Blanche Elizabeth Saldanha, Brian W Tempest, Saira Ramasastry, Sridhar Gorthi, Bernard Munos, Cherylann Pinto, VS Mani, Glenn Saldanha, Glenn Saldanha.
it’s miles indexed on the BSE with a BSE Code of 532296 , NSE with an NSE image of GLENMARK and ISIN of INE935A01035. it is Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. it is auditors are Arthur Andersen & pals, charge Waterhouse, Suresh Surana & pals LLP, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP
Share Target Price 2022 2023 2025 2030 of Glenmark
Glenmark pharma share price target 2022
searching at this inside the coming years, Glenmark percentage price target 2022 is anticipated to expose you the first target of Rs 585 soon. After this goal you try to maintain the second target for Rs.25.
Glenmark pharma share price target 2023
If the management is visible displaying boom inside the sales position of its product like this, then the share price of Glenmark may be seen displaying you the first target of Rs 795 with the aid of 2025. After that, have a look at 945 rupees to be the second target interest.
Glenmark pharma share price target 2025
With its commercial enterprise improvement inside the coming years, Glenmark share price target is going to reveal you the first target of Rs 1530 by means of 2025. Then the second one target you must search for is Rs 1870.
Glenmark pharma share price target 2030
If the agency is visible showing increase as planned in the end, then by 2030, Glenmark’s share price target is possibly to reveal you round Rs 3400.
FAQ – fundamental
Is GLENMARK pharmaceuticals proper for long time investment?
As on 10-Dec-2021, the fundamentals of GLENMARK pharmaceuticals look average and as a result you could watch for the results to enhance to make investments for long time ! See financial overall performance of GLENMARK pharmaceuticals . Please have a look at the other parameters such as Valuation, price Momentum, news & corporate Governance and/or consult an investment advisor before taking an investment choice!
Is GLENMARK pharmaceuticals UnderValued or hyped up?
As on 10-Dec-2021, GLENMARK pharmaceuticals is under Valued primarily based at the estimates of intrinsic price and hence may be a terrific shopping for opportunity according to share Valuation at the moment!
what is the Intrinsic value of GLENMARK pharmaceuticals ?
As on 10-Dec-2021, the Intrinsic fee of GLENMARK pharmaceuticals is Rs. 1,121.28 decided primarily based on Median of the three historical fashions.
fair fee [Median EV / EBIDTA Model] : Rs. 953.50
fair price [Median EV / Sales Model] : Rs. 1,191.10
truthful cost [Median Price / Sales Model] : Rs. 1,121.28
Median truthful value of GLENMARK pharmaceuticals : Rs. 1,121.28
Is GLENMARK pharmaceuticals trading at a top rate or cut price?
As on 10-Dec-2021, GLENMARK pharmaceuticals is buying and selling at a reduction of –53% based totally on the estimates of Median Intrinsic value!